140 related articles for article (PubMed ID: 38431747)
21. Peg-asparaginase for acute lymphoblastic leukemia.
Rytting M
Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
[TBL] [Abstract][Full Text] [Related]
22. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Lim HL; Teo CP; Wong K; Kueh YK
Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
[TBL] [Abstract][Full Text] [Related]
23. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
[TBL] [Abstract][Full Text] [Related]
24. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia.
Ettinger LJ; Kurtzberg J; Voûte PA; Jürgens H; Halpern SL
Cancer; 1995 Mar; 75(5):1176-81. PubMed ID: 7850718
[TBL] [Abstract][Full Text] [Related]
25. High-dose methotrexate and asparaginase for the treatment of children with acute lymphoblastic leukemia: why and how?
Kamen BA
J Pediatr Hematol Oncol; 2004 Jun; 26(6):333-5. PubMed ID: 15167344
[No Abstract] [Full Text] [Related]
26. Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?
Patil S; Coutsouvelis J; Spencer A
Cancer Treat Rev; 2011 May; 37(3):202-7. PubMed ID: 20822851
[TBL] [Abstract][Full Text] [Related]
27. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
Thu Huynh V; Bergeron S
Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
[TBL] [Abstract][Full Text] [Related]
28. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
Chen SH
Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
[TBL] [Abstract][Full Text] [Related]
29. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
30. 50 Years Ago in The Journal of Pediatrics: L-Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: Optimizing Efficacy and Minimizing Toxicity.
Bourgeois W
J Pediatr; 2020 Sep; 224():86. PubMed ID: 32826033
[No Abstract] [Full Text] [Related]
31. How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia.
Burke MJ
Future Oncol; 2014 Dec; 10(16):2615-27. PubMed ID: 24983955
[TBL] [Abstract][Full Text] [Related]
32. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
Salvador C; Meister B; Crazzolara R; Kropshofer G
Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026
[No Abstract] [Full Text] [Related]
33. l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphoma.
Heenan JM; Hooper AJ; Burnett JR; Cooney J
Pathology; 2021 Dec; 53(7):924-926. PubMed ID: 34049714
[No Abstract] [Full Text] [Related]
34. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
[No Abstract] [Full Text] [Related]
35. Pegaspargase for acute lymphoblastic leukemia.
Med Lett Drugs Ther; 1995 Mar; 37(944):23-4. PubMed ID: 7877556
[No Abstract] [Full Text] [Related]
36. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.
Rathi B; Azad RK; Vasudha N; Hissaria P; Sawlani V; Gupta RK
Pediatr Neurosurg; 2002 Oct; 37(4):203-5. PubMed ID: 12372914
[TBL] [Abstract][Full Text] [Related]
37. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
[TBL] [Abstract][Full Text] [Related]
38. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report.
Misgar RA; Laway BA; Rahaman SH; Wani AI; Bashir MI; Bhat JR
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):439-41. PubMed ID: 25210761
[TBL] [Abstract][Full Text] [Related]
39. Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.
Salzer W; Bostrom B; Messinger Y; Perissinotti AJ; Marini B
Leuk Lymphoma; 2018 Aug; 59(8):1797-1806. PubMed ID: 29045165
[TBL] [Abstract][Full Text] [Related]
40. Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA.
Keating GM
BioDrugs; 2013 Aug; 27(4):413-8. PubMed ID: 23794007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
